NewEdge Advisors’s 1Life Healthcare ONEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-315
Closed -$5 4338
2022
Q4
$5 Buy
+315
New +$5.32K ﹤0.01% 3824
2021
Q2
Sell
-16,048
Closed -$627K 1207
2021
Q1
$627K Sell
16,048
-11,877
-43% -$558K 0.02% 605
2020
Q4
$1.22M Buy
+27,925
New +$954K 0.04% 371
2020
Q3
Sell
-31,226
Closed -$1.13M 997
2020
Q2
$1.13M Buy
+31,226
New +$880K 0.04% 328

NewEdge Advisors's ONEM Position: Q1 2023 in Review

NewEdge Advisors sold out of 1Life Healthcare (ONEM) in Q1 2023, closing a stake of 315 shares — an estimated $5 sold.

NewEdge Advisors first reported a position in ONEM in Q2 2020 and held it in 4 quarters. The position peaked at $1.22M in Q4 2020. 0 funds tracked by Wall St. Rank hold ONEM as of Q1 2023.

  • NewEdge Advisors reported no remaining 1Life Healthcare position as of Q1 2023 after selling out during the quarter.
  • NewEdge Advisors sold 315 1Life Healthcare shares in Q1 2023, an estimated $5.
  • NewEdge Advisors first reported a position in 1Life Healthcare in Q2 2020 and held it in 4 quarters.
  • NewEdge Advisors's 1Life Healthcare position peaked at $1.22M in Q4 2020.
  • 0 funds tracked by Wall St. Rank held 1Life Healthcare as of Q1 2023.

Based on NewEdge Advisors's 13F filing for Q1 2023, filed 12 May 2023.